$47MSeries A, 27 April 2026
Oversubscribed Series A to advance its physics and AI drug design platform; company formerly named Atommap.
- Amount
- $47M
- Stage
- Series A
- Announced
- 27 April 2026
- Lead
- Sutter Hill Ventures
- Other investors
- Chemistry, Alexandria Venture Investments, NY Ventures
- Use of funds
- Oversubscribed Series A to advance its physics and AI drug design platform; company formerly named Atommap.
- Checked
- Announced by the company
- Sources
- Fathom Therapeutics (formerly Atommap) raises $47M Series A citybiz.co
Fathom Therapeutics (formerly Atommap) raises $47M Series A pulse2.com